Not available
Quote | Nuvectra Corporation (NASDAQ:NVTR)
Last: | $ |
---|---|
Change Percent: | -23.17% |
Open: | $0.175 |
Close: | $0.13 |
High: | $0.1894 |
Low: | $0.13 |
Volume: | 2,591,709 |
Last Trade Date Time: | 11/21/2019 04:46:32 pm |
News | Nuvectra Corporation (NASDAQ:NVTR)
Gainers: Nortech Systems (NASDAQ: NSYS ) +98% . More news on: Nortech Systems Incorporated, FuelCell Energy, Inc., Cardlytics, Inc., Stocks on the move, Read more ...
Alnylam Pharmaceuticals (NASDAQ: ALNY ) initiated with Buy rating and $110 (21% upside) price target at BofA Merrill Lynch. More news on: Alnylam Pharmaceuticals, Inc., Arena Pharmaceuticals, Inc., National Vision Holdings, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Message Board Posts | Nuvectra Corporation (NASDAQ:NVTR)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Court-Supervised Process Has No Impact on Safety or Functionality of Algovita Device; Company Continuing to Support Physicians PLANO, Texas, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR) (“Nuvectra” or the “Company”), a neurostimulati...
PLANO, Texas, Oct. 18, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced it has submitted supplementary chemical composition and biocompatibility data to the U.S. Food and Drug Administration (FDA) in support of the Comp...
PLANO, Texas, Sept. 20, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced the appointment of Jennifer Kosharek as Chief Financial Officer, effective September 16, 2019. Ms. Kosharek will assume the role of Chief Financia...